Az innovációs és RD-képességek javítása a gyógyszeripar fejlődésének fellendítése érdekében

Mar 26, 2022

Hagyjon üzenetet

The platform construction project of "Science and Technology China" is a platform for the China Association for Science and Technology to build the brand of "Science and Technology China", promote the integration of science and technology and economy, and systematically implement the spirit of the important instructions for replying to scientific and technological workers, and serve and coordinate the epidemic prevention and control and economic and social development work. important measure.

According to the "Science and Technology China" platform construction plan, the Academic Department of the China Association for Science and Technology will focus on the needs of the "Science and Technology China" pilot cities (parks) and organize the construction of the "Science and Technology China" technology application case library construction project. The project focuses on information technology, intelligent manufacturing, biomedicine, new materials, industrial Internet, new energy, as well as agriculture, forestry, aquatic products, and other fields related to the foundation of the national economy. By exploring the evaluation criteria, collection mechanism, and review mechanism for the application of technological achievements, the technical characteristics, scope of application, typical results, technical evaluation, acquisition methods, etc. Promote the expansion of the practical value of existing achievements, and strive to build a technology and economic integration model that leads demand growth with technological application cases drives industrial development with demand growth and drives the rapid transformation of innovative technological achievements with industrial development.

A Kínai Tudományos és Technológiai Szövetség jóváhagyásával a Kínai Gyógyszerészeti Szövetséget bízták meg azzal, hogy a kínai orvosbiológiai RD-kérelmek adatbázisának összegyűjtéséért és felépítéséért felelős. A konkrét vállalkozási osztály a Kínai Gyógyszerészeti Szövetség Gyógyszerklinikai Értékelési és Kutatási Szakmai Bizottsága.

The construction of the case library will be based on telling the story of China's drug research and development and singing the voice of China in the field of drug research and development. The construction of the case library aims at representative and exemplary high-quality cases of domestic research and development of drugs in my country, which not only provides broader research and development ideas for the follow-up research and development of domestic research and development enterprises but also further enhances the public's confidence in my country's independent research and development of drugs and enhances national pride. feel. The construction of the case library includes various chemical drugs, traditional Chinese medicines, and biological products for prevention and treatment. The contents of the cases involved mainly include a brief analysis of the characteristics and advantages of pharmacological effects such as the mechanism of action of the drug, the target of the action, and the toxic and side effects; Its demonstration; focus on all the characteristics and highlights, advantages and demonstration of the drug clinical trial design, trial implementation, data analysis and results; drug marketing approval and clinical positioning characteristics and advantages.

Under the guidance of experts from the Center for Drug Evaluation (CDE) of the State Food and Drug Administration, carefully organized by leaders of the Chinese Pharmaceutical Association, and actively supported and strictly reviewed by experts from various medical institutions organized by the Professional Committee of Drug Clinical Evaluation and Research of the Chinese Pharmaceutical Association, The Chinese Pharmaceutical Association issued an invitation to all drug RD units in China to enter the database of successful drug RD cases. Each RD unit provided the content of the draft cases. The cases reviewed and approved by the expert team of experts were included in the application case database of biopharmaceutical RD in China. It will be displayed in the "Science and Technology Innovation China" case library of the China Association for Science and Technology. Brand display and demonstration promotion for new drugs developed in China.


Forrás: Guangming.com

A szálláslekérdezés elküldése